New Delhi: The country has been in a constant battle with rising infertility that has had a severe impact on how couple’s look at pregnancy and expanding their families today. Rising infertility amongst the younger population has created a void that conventional fertility treatments and lifestyle changes have been unable to address. The fertility segment, like most of the other health segments, has developed immensely in the past few years, the growth has remained unaffected by the onset of the pandemic. For better insights into the fertility segment, ETHealthworld Fertility Conclave commencing on February 25, 2022, will bring together top health experts and leaders from the fertility segment.
The second edition of ETHealthworld Fertility Conclave powered by Bharat Serums and Vaccines Ltd will host panellists from across the country who will deliberate, ideate and put forth suggestions so as to make India’s fertility sector one of the best in the world. The conclave will look into the new ART Act, Surrogacy Act along with digital technology and how it will transform and etch-out the new normal of the fertility industry.
The conclave will feature a keynote session on ‘Public Health Focus on Infertility Prevention, Detection, and Management’ with Dr Sanjay Chauhan from National Institute for Research in Reproductive Health which will focus on how the gap created in the identification of infertility and treatment can be filled by focussing towards improving public health and fertility care.
The conclave will also host a session with Vishwanath Swarup, Chief Operating Officer, Bharat Serums and Vaccines Limited who will bring in an expert’s perspective on how the IVF industry can adapt to the new normal.
ETHealthworld Fertility Conclave brings IVF experts from all over the country, who will discuss legal, financial, social and medical issues that are currently deep rooted in the fertility segment during these panel discussions.
‘Decoding and Understanding ART Act : The way forward’
The rapidly increasing percolation of fertility treatments generates the need for legislation to regulate the segment. The ART Act introduced recently intends to put a stop to rising malpractices in the ART process. The topic for the discussion here would be ‘Decoding and Understanding ART Act : The way forward’. The panel will host eminent fertility experts including Dr Manish Banker, Medical Director, Nova IVF Fertility, Dr K Madangopal, Senior Consultant, Health, Niti Aayog, Government of India, Dr Kamini Rao, Medical Director, Milann-The Fertility Centre, Amit Karkhanis, Senior Lawyer, Practicing Medico-Legal Issues, Dr Kshitiz Murdia, CEO, Indira IVF and Dr Jaydeep Tank, Obstetrician and Gynaecologist, IVF Consultant, Ashwini Maternity and Surgical Hospital.
‘Growth Prospects of Insurance in IVF: Impact on payers, providers, and patients’
As the market for IVF and fertility treatment grows in cities across the country, there is a high probability of more insurance providers expanding their offering to the segment with more and and more patients turning to them to cover the cost of treatment. To deliberate on ‘Growth Prospects of Insurance in IVF: Impact on payers, providers, and patients’, the panel will witness the likes of Dr Jaideep Malhotra, Founder, Rainbow IVF, Dr Neena Malhotra, General Secretary, Indian Fertility Society, Dr Kaberi Banerjee Medical Director, Advance Fertility and Gynaecological Center and Dr S Prakash Subbarayan, Managing Director, Star Health and Allied Insurance Co Ltd.
‘ART Act will transform the IVF segment’
The introduction of the ART Act can have all kinds of implications on the fertility segment in the ways in which it currently operates. The panel will thus try to shed light on how the ‘ART Act will transform the IVF segment’ and whether it will be able to regulate the segment well enough to considerably reduce malpractices. The panel will host Dr Sonia Malik, Director & HOD, Nova Southend Fertility & IVF, Dr Nandita Palshetkar, President Elect, Indian Society For Assisted Reproduction, Dr Firuzah Parikh, Director, Department of Assisted Reproduction, Jaslok Hospital and Research Centre, Dr Hrishikesh Pai, President Elect, FOGSI, Medical Director, Bloom IVF and Dr Sonali Kusum, Assistant Professor, Law, Tata Institute of Social Sciences.
Kanupriya Agarwal India’s first IVF baby will share her journey and how stereotypes around IVF can be effectively broken in a fireside chat session. Do join in to listen to her conversation and her opinions.
‘How Entrepreneurs can move IVF into the future’
The rapid expansion of the fertility segment has not only led to the propping up of new fertility set-ups, but has also enabled the entry of corporates and entrepreneurs to the now crowded fertility segment. The panellists will discuss how the segment can counter the wrongdoings creeping into the segment and keep patients as the priority over any business being run in the healthcare segment. The panel discussion on ‘How Entrepreneurs can move IVF into the future’ will host Dr Aniruddha Malpani, Medical Director, Malpani IVF Clinic, Dr Madhuri Milind Patil, Clinical Director, Dr Patil’s Fertility and Endoscopy Clinic, Dr Parikshit Tank, Treasurer- FOGSI, Consultant Obstetrician and Gynaecologist, ART Specialist, Ashwini Maternity and Surgical Hospital, Anubhav Prashant, COO, Apollo Cradle and Apollo Fertility and Dr Basab Mukherjee, Vice President, FOGSI.
‘Putting AI in IVF: Is it a Help or Hurt?’
The inculcation of technology in the fertility segment can not only significantly improve success rates and precision, but can also improve care delivery for both parents and the child born through the magic of science. Experts will shed light on both positives and negatives of depending on technology for treatment in the panel discussion on ‘Putting AI in IVF: Is it a Help or Hurt?’. The panel will host Dr Jaydeep Tank, Obstetrician and Gynaecologist, IVF Consultant, Ashwini Maternity and Surgical Hospital, Dr Sunita Tandulwadkar, HOD (OBGYN) & Chief, IVF and Endoscopy Centre, Ruby Hall Clinic, Dr Asha Baxi, Gynaecologist and Infertility Expert, Motherhood Hospitals, Nitiz Murdia, Director and Co-Founder, Indira IVF, Dr Nikita Lad, Chief IVF Consultant, Apollo Fertility, Mumbai) and Dr Keshav Malhotra, Director, Rainbow IVF.
‘Is India turning out to be world’s capital for IVF treatment?’
Rapidly developing fertility infrastructure in the country can pave the way for India to become the fertility capital of the world. What obstructions does the segment need to overcome to become the best out there? Listen to experts addressing questions on ‘Is India turning out to be world’s capital for IVF treatment?’ The panel will host the likes of Dr (Prof) Pankaj Talwar, Head Medical Services, Birla Fertility and IVF, Prof Abha Majumdar, Director, Centre of IVF & Human Reproduction, Sir Ganga Ram Hospital, Dr Rita Bakshi, CEO and Founder, RISAA IVF, Dr Arunima Haldar, Consultant, IVF & Reproductive Medicine, Manipal Hospital and Vinesh Gadhia, CEO, India Operations, ART Fertility Clinics.
The event will also witness the launch of ETHealthworld’s exclusive Coffee Table Book: ETHealthworld Innovatory Gynaecologists of India featuring the stories of top gynaecologists from all over the country.
The congregation of eminent experts from the fertility segment with years of experience and caliber will engage in discussion to ideate, formulate and put forth suggestions to effectively implement solutions to ensure that fertility treatment is accessible, affordable, provides quality care and fulfils the dreams of parenthood.
Register on the link to join in: https://bit.ly/3BrNOPX